NB is characterized by a non-random intratumoral heterogeneity controlled by super-enhancer-associated transcription factor (TF), which defines two divergent phenotypes: the committed adrenergic cells and an undifferentiated primitive mesenchymal subset identified by the expression of the CD133 marker [43]. Here, TF is linked to neuroblastoma.